Motherson Sumi to deliver 40% ROCE as promised

Published on Tue, Nov 08, 2011 at 12:22 |  Source : CNBC-TV18

Updated at Tue, Nov 08, 2011 at 15:11  

3368 Investors following Motherson Sumi. Share this News with them.
0
0
Share on Tumblr
Vivek Chaand Sehgal, Vice Chairman, Motherson Sumi

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

During the second quarter FY12, Motherson Sumi 's revenue was up 19.4% at Rs 2,338 crore versus Rs 1,957 crore (YoY) and profit after tax (PAT) was down 72% at Rs 24.2 crore versus Rs 85.9 crore (YoY). The company's operating profit margin (OPM) was at 5.5% versus 10.6% (YoY).

As the company's biggest customer Maruti is coming out of trouble, Vice Chairman Vivek Chaand Sehgal said that the company will deliver 40% return on capital employed (ROCE) as promised. Morover, he indicated that the car sales in Europe were not impacted by the prevailing uncertainties.

Here is the edited transcript of his interview to CNBC-TV18. Also watch the accompanying video.

Q: What were the difficulties that kept the margins under pressure this quarter?

A: The margins are not really affected. We are in the process of growing very rapidly. When we grow, we have to put up a new facility. To put in new facilities, one has to shares the fair gain of the expenditure. All of them are coming in at the same time.

Unfortunately, one of our big customers has gone a bit into trouble, but is now coming out of that. They have four new plants that are being commissioned or have already started initial production.

The sales are up. We are up 98.5% on a consolidated basis and almost 19% on a standalone basis. We are very conservative when it comes to accounting. We will mark to market and we have done that.

Q: Shouldn't we extrapolate this quarter's performance for the second half of the year? As Maruti comes to some level of stability, will your second half do a lot better, both in terms of revenue and bottomline? How much better can it be?

A: We have never given quarter-on-quarter performance. We will deliver around 40% ROCE as promised.

Q: As far as Samvardhana Motherson Reflectec (SMR) is concerned, what has been the margins performance there this quarter? Because the situation in Europe is very volatile, how does the second half of the fiscal look for SMR particularly?

A: We can't connect the European economy to the car sales. The car sales have been doing very well. The three German biggest car makers are doing phenomenally well. One could not connect car sales to what is happening in the euro zone. SMR is going through its growth pattern, which was very important. We have picked up orders and almost USD 800 million have been announced.

We just inaugurated our Hungarian plant. Next month, we will inaugurate our Brazilian plant. It will take about two-three months to come. SMR has grown in euro terms about 13.5%. If you are growing at 13.5%, it is very difficult to understand why everybody says that the car production is down.

Q: For Peguform, you are looking for a shareholder approval for a qualified institutional placement (QIP). How much are you looking to raise? What it the timeline? When we can expect to hear about the fund raising?

A: Peguform is totally funded by loans. QIP is an enabling resolution. Once Peguform comes in and the new growth patterns come in from our customers, we would need more funding. It is just an enabling resolution. When the market decides and we feel that we need the money, we would do so. Our balance sheet is very strong. So, we don't need to do it.

  

Trending News

Business News

Pre-book the Samsung Galaxy S III on Snapdeal for Rs. 250
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

Sources Say CNBC-TV18 Exclusive RIL, PwC Cases, If Re-Applied To Come Under New Guidelines

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!